FORCED TREATMENT AS A TYPE OF ALTERNATIVE METHOD OF PREVENTING AND FIGHTING THE ILLEGAL TRAFFICKING OF NARCOTICS, PSYCHOTROPIC SUBSTANCES, THEIR ANALOGUES AND PRECURSORS

Abstract

The scientific article examines the specifics of the application of forced treatment to drug addicts who have committed criminal offenses in the field of illegal trafficking of narcotic drugs, psychotropic substances, their analogues and precursors. It is indicated the effectiveness of the combination of criminal-legal and medical measures of influence in order to prevent the commission of new criminal offenses by these persons and their loss of public danger. The legal nature of forced treatment is investigated, the disadvantages and advantages of this criminal-legal measure are indicated. It is pointed out the feasibility of revising the concept of forced treatment in criminal law in terms of expanding its content and scope for drug addicts, taking into account the peculiarities and specifics of this type of disease and its combination with the commission of criminal offenses. Compulsory treatment applied to drug addicts, along with criminal punishment, are important means of combating criminal offenses in the field of illegal trafficking of narcotic drugs, psychotropic substances and their analogues. The combination of the effective application of all types of treatment of drug addicts and the implementation of criminal law forms of influence can lead to the achievement of the necessary result – obtaining a balanced mechanism of influence on drug crime at the individual and general level. At the same time, priority should be given to forced treatment, which is able to maximally achieve the specific goal of the criminal law. Compulsory treatment of drug addicts who have committed a criminal offense in the field of illegal trafficking of narcotic drugs, psychotropic substances, and their analogues is the most promising type of coercive measures. It should be noted that such coercive measures can be adapted and formulated in the State Drug Policy Strategy.